Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group

BACKGROUND: The urokinase plasminogen activator receptor is highly expressed and its gene is amplified in about 50% of pancreatic ductal adenocarcinomas; this last feature is associated with worse prognosis. It is unknown whether the level of its soluble form (suPAR) in urine may be a diagnostic-pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorio, Claudio, Mafficini, Andrea, Furlan, Federico, Barbi, Stefano, Bonora, Antonio, Brocco, Giorgio, Blasi, Francesco, Talamini, Giorgio, Bassi, Claudio, Scarpa, Aldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213238/
https://www.ncbi.nlm.nih.gov/pubmed/21999221
http://dx.doi.org/10.1186/1471-2407-11-448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213238/
https://www.ncbi.nlm.nih.gov/pubmed/21999221
http://dx.doi.org/10.1186/1471-2407-11-448

Ejemplares similares